The Expression and Function of HSV ICP47 and Its Promoter in Mice

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 2023 Oct 30

PMID 37902400

Authors

Thilaga Velusamy

Navneet Singh

Sarah Croft

Stewart Smith

David C Tscharke

Affiliations

Soon will be listed here.

Abstract

Immune evasion and latency are key mechanisms that underlie the success of herpesviruses. In each case, interactions between viral and host proteins are required and due to co-evolution, not all mechanisms are preserved across host species, even if infection is possible. This is highlighted by the herpes simplex virus (HSV) protein immediate early-infected cell protein (ICP)47, which inhibits the detection of infected cells by killer T cells and acts with high efficiency in humans, but poorly, if at all in mouse cells. Here, we show that ICP47 retains modest but detectable function in mouse cells, but in an model we found no role during acute infection or latency. We also explored the activity of the ICP47 promoter, finding that it could be active during latency, but this was dependent on genome location. These results are important to interpret HSV pathogenesis work done in mice.

Citing Articles

Lytic promoter activity during herpes simplex virus latency is dependent on genome location.

Singh N, Zachariah S, Phillips A, Tscharke D J Virol. 2024; 98(11):e0125824.

PMID: 39431845 PMC: 11575402. DOI: 10.1128/jvi.01258-24.

Integrating pan-genome and reverse vaccinology to design multi-epitope vaccine against Herpes simplex virus type-1.

Roy A, Swetha R, Basu S, Biswas R, Ramaiah S, Anbarasu A 3 Biotech. 2024; 14(7):176.

PMID: 38855144 PMC: 11153438. DOI: 10.1007/s13205-024-04022-6.

Multi-targeted loss of the antigen presentation molecule MR1 during HSV-1 and HSV-2 infection.

Samer C, McWilliam H, McSharry B, Velusamy T, Burchfield J, Stanton R iScience. 2024; 27(2):108801.

PMID: 38303725 PMC: 10831258. DOI: 10.1016/j.isci.2024.108801.

References

Ellison A, Yang L, Voytek C, Margolis T . Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains. Virology. 2000; 268(1):17-28. DOI: 10.1006/viro.1999.0158. View

Wakim L, Jones C, Gebhardt T, Preston C, Carbone F . CD8(+) T-cell attenuation of cutaneous herpes simplex virus infection reduces the average viral copy number of the ensuing latent infection. Immunol Cell Biol. 2008; 86(8):666-75. DOI: 10.1038/icb.2008.47. View

Weir H, CALDER J, Stow N . Binding of the herpes simplex virus type 1 UL9 gene product to an origin of viral DNA replication. Nucleic Acids Res. 1989; 17(4):1409-25. PMC: 331812. DOI: 10.1093/nar/17.4.1409. View

van Lint A, Ayers M, Brooks A, Coles R, Heath W, Carbone F . Herpes simplex virus-specific CD8+ T cells can clear established lytic infections from skin and nerves and can partially limit the early spread of virus after cutaneous inoculation. J Immunol. 2003; 172(1):392-7. DOI: 10.4049/jimmunol.172.1.392. View

Greco A, Simonin D, Diaz J, Barjhoux L, Kindbeiter K, Madjar J . The DNA sequence coding for the 5' untranslated region of herpes simplex virus type 1 ICP22 mRNA mediates a high level of gene expression. J Gen Virol. 1994; 75 ( Pt 7):1693-702. DOI: 10.1099/0022-1317-75-7-1693. View

Allan R, Waithman J, Bedoui S, Jones C, Villadangos J, Zhan Y . Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity. 2006; 25(1):153-62. DOI: 10.1016/j.immuni.2006.04.017. View

Clements J, Watson R, Wilkie N . Temporal regulation of herpes simplex virus type 1 transcription: location of transcripts on the viral genome. Cell. 1977; 12(1):275-85. DOI: 10.1016/0092-8674(77)90205-7. View

Koff A, Tegtmeyer P . Characterization of major recognition sequences for a herpes simplex virus type 1 origin-binding protein. J Virol. 1988; 62(11):4096-103. PMC: 253840. DOI: 10.1128/JVI.62.11.4096-4103.1988. View

Burgos J, Serrano-Saiz E, Sastre I, Valdivieso F . ICP47 mediates viral neuroinvasiveness by induction of TAP protein following intravenous inoculation of herpes simplex virus type 1 in mice. J Neurovirol. 2006; 12(6):420-7. DOI: 10.1080/13550280601009546. View

10.

Fruh K, Ahn K, Djaballah H, SEMPE P, van Endert P, Tampe R . A viral inhibitor of peptide transporters for antigen presentation. Nature. 1995; 375(6530):415-8. DOI: 10.1038/375415a0. View

11.

Wang K, Lau T, Morales M, Mont E, Straus S . Laser-capture microdissection: refining estimates of the quantity and distribution of latent herpes simplex virus 1 and varicella-zoster virus DNA in human trigeminal Ganglia at the single-cell level. J Virol. 2005; 79(22):14079-87. PMC: 1280223. DOI: 10.1128/JVI.79.22.14079-14087.2005. View

12.

Singh N, Tscharke D . Herpes Simplex Virus Latency Is Noisier the Closer We Look. J Virol. 2019; 94(4). PMC: 6997768. DOI: 10.1128/JVI.01701-19. View

13.

Hill A, Jugovic P, York I, Russ G, Bennink J, Yewdell J . Herpes simplex virus turns off the TAP to evade host immunity. Nature. 1995; 375(6530):411-5. DOI: 10.1038/375411a0. View

14.

Croft S, Wong Y, Smith S, Flesch I, Tscharke D . Surprisingly Effective Priming of CD8 T Cells by Heat-Inactivated Vaccinia Virus Virions. J Virol. 2020; 94(20). PMC: 7527048. DOI: 10.1128/JVI.01486-20. View

15.

Tomazin R, Hill A, Jugovic P, York I, Van Endert P, Ploegh H . Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. EMBO J. 1996; 15(13):3256-66. PMC: 451888. View

16.

Yewdell J, ESQUIVEL F, Arnold D, Spies T, Eisenlohr L, Bennink J . Presentation of numerous viral peptides to mouse major histocompatibility complex (MHC) class I-restricted T lymphocytes is mediated by the human MHC-encoded transporter or by a hybrid mouse-human transporter. J Exp Med. 1993; 177(6):1785-90. PMC: 2191053. DOI: 10.1084/jem.177.6.1785. View

17.

Kubat N, Amelio A, Giordani N, Bloom D . The herpes simplex virus type 1 latency-associated transcript (LAT) enhancer/rcr is hyperacetylated during latency independently of LAT transcription. J Virol. 2004; 78(22):12508-18. PMC: 525101. DOI: 10.1128/JVI.78.22.12508-12518.2004. View

18.

Heiman M, Kulicke R, Fenster R, Greengard P, Heintz N . Cell type-specific mRNA purification by translating ribosome affinity purification (TRAP). Nat Protoc. 2014; 9(6):1282-91. PMC: 4102313. DOI: 10.1038/nprot.2014.085. View

19.

Russell T, Tscharke D . Lytic Promoters Express Protein during Herpes Simplex Virus Latency. PLoS Pathog. 2016; 12(6):e1005729. PMC: 4922595. DOI: 10.1371/journal.ppat.1005729. View

20.

Schang L, Hu M, Flores Cortes E, Sun K . Chromatin-mediated epigenetic regulation of HSV-1 transcription as a potential target in antiviral therapy. Antiviral Res. 2021; 192:105103. PMC: 8277756. DOI: 10.1016/j.antiviral.2021.105103. View